Antitumour activity of oxaliplatin in neuroblastoma cell lines

This publication has 13 references indexed in Scilit:

• Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis
  British Journal of Cancer, 1997
• Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
  Annals of Oncology, 1996
• Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel
  Biochemical Pharmacology, 1996
• Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck
  Oral Oncology, 1996
• Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques
  Cytometry, 1996
• Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
  Annals of Oncology, 1996
• Phase I study of oxaliplatin in patients with advanced cancer
  Cancer Chemotherapy and Pharmacology, 1990
• Prognostic factors in neuroblastoma
  Cancer, 1987
• Algorithm AS 190: Probabilities and Upper Quantiles for the Studentized Range
  Journal of the Royal Statistical Society Series C: Applied Statistics, 1983
• Platinum Compounds: a New Class of Potent Antitumour Agents
  Nature, 1969